1. Home
  2. OCGN vs IHRT Comparison

OCGN vs IHRT Comparison

Compare OCGN & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • IHRT
  • Stock Information
  • Founded
  • OCGN 2013
  • IHRT N/A
  • Country
  • OCGN United States
  • IHRT United States
  • Employees
  • OCGN N/A
  • IHRT N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • IHRT Broadcasting
  • Sector
  • OCGN Health Care
  • IHRT Consumer Discretionary
  • Exchange
  • OCGN Nasdaq
  • IHRT Nasdaq
  • Market Cap
  • OCGN 252.4M
  • IHRT 296.6M
  • IPO Year
  • OCGN N/A
  • IHRT 2019
  • Fundamental
  • Price
  • OCGN $0.91
  • IHRT $2.40
  • Analyst Decision
  • OCGN Strong Buy
  • IHRT Buy
  • Analyst Count
  • OCGN 3
  • IHRT 3
  • Target Price
  • OCGN $5.67
  • IHRT $3.00
  • AVG Volume (30 Days)
  • OCGN 4.3M
  • IHRT 1.3M
  • Earning Date
  • OCGN 11-08-2024
  • IHRT 11-07-2024
  • Dividend Yield
  • OCGN N/A
  • IHRT N/A
  • EPS Growth
  • OCGN N/A
  • IHRT N/A
  • EPS
  • OCGN N/A
  • IHRT N/A
  • Revenue
  • OCGN $4,700,000.00
  • IHRT $3,803,046,000.00
  • Revenue This Year
  • OCGN N/A
  • IHRT $6.56
  • Revenue Next Year
  • OCGN N/A
  • IHRT N/A
  • P/E Ratio
  • OCGN N/A
  • IHRT N/A
  • Revenue Growth
  • OCGN N/A
  • IHRT N/A
  • 52 Week Low
  • OCGN $0.36
  • IHRT $0.81
  • 52 Week High
  • OCGN $2.11
  • IHRT $3.12
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 44.59
  • IHRT 59.51
  • Support Level
  • OCGN $0.85
  • IHRT $2.24
  • Resistance Level
  • OCGN $0.94
  • IHRT $2.50
  • Average True Range (ATR)
  • OCGN 0.08
  • IHRT 0.24
  • MACD
  • OCGN -0.01
  • IHRT 0.01
  • Stochastic Oscillator
  • OCGN 19.64
  • IHRT 62.23

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based diversified media and entertainment company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

Share on Social Networks: